Farallon Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$381M |
| 2 |
Microsoft
MSFT
|
+$266M |
| 3 |
Salesforce
CRM
|
+$235M |
| 4 |
K
Kellanova
K
|
+$186M |
| 5 |
Aramark
ARMK
|
+$178M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Airbnb
ABNB
|
+$319M |
| 2 |
HCP
HashiCorp, Inc. Class A Common Stock
HCP
|
+$221M |
| 3 |
Aon
AON
|
+$181M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$180M |
| 5 |
HES
Hess
HES
|
+$150M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 37.95% |
| 2 | Technology | 14.96% |
| 3 | Financials | 12.32% |
| 4 | Communication Services | 7.9% |
| 5 | Industrials | 5.68% |
Similar funds
Farallon Capital Management's Q1 2025 Portfolio in Review
As of Q1 2025, Farallon Capital Management held 168 positions worth $20.9B, down 8.5% from $22.8B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Farallon Capital Management withdrew a net $1.04B in Q1 2025, closing 22 positions and reducing 28 holdings. Its most notable exit was Airbnb, an estimated $319M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 34% a quarter earlier, followed by Technology and Financials.
Against the trend, Farallon Capital Management opened a new position in Intra-Cellular Therapies Inc. worth $403M.
- Farallon Capital Management's largest Q1 2025 buy was Intra-Cellular Therapies Inc.: 3,055,000 shares worth $403M.
- Farallon Capital Management added most to Microsoft in Q1 2025, an estimated $266M increase.
- Farallon Capital Management's biggest Q1 2025 reduction was Aon, cutting an estimated $181M.
- Farallon Capital Management fully exited Airbnb in Q1 2025, selling an estimated $319M.
- Farallon Capital Management's ten largest holdings make up 40% of its $20.9B portfolio in Q1 2025.
- Farallon Capital Management opened 18 new positions and closed 22 in Q1 2025.
- Farallon Capital Management's portfolio value fell 8.5% quarter-over-quarter to $20.9B.
Based on Farallon Capital Management's 13F filing for Q1 2025, filed 15 May 2025.